| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/04/1994 | CN1086144A Aqueous dispersions of zein and preparation thereof |
| 05/04/1994 | CN1086143A Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/04/1994 | CA2102251A1 Method for the one-dimensional fractionation and identification of glycans, and the use of this method for setting up data bases and for the determination of the structure of glycans and for the relative determination of the stokes radii glycans |
| 05/03/1994 | US5308889 Medical article for surgery |
| 05/03/1994 | US5308836 Pharmaceutical composition of stabilized [Leu13 ]-motilin-Hse |
| 05/03/1994 | US5308835 Cloning, gene expression, vaccine against diarrheal diseases including cholera |
| 05/03/1994 | US5308834 Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
| 05/03/1994 | US5308760 Crystal proteins of Bacillus thuringiensis, genes encoding them, and host expressing them |
| 05/03/1994 | US5308752 Determination of antibody binding to dystrophin-protein complex |
| 05/03/1994 | US5308750 Binders for hepatitis C virus and hybridomas and antigens |
| 05/03/1994 | US5308459 Biosynthetic cerebrospinal fluid control and method of use |
| 05/03/1994 | CA1329308C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 05/03/1994 | CA1329307C Purification of monomeric interferon |
| 05/03/1994 | CA1329157C Method for activating gene technologically produced, heterologous, eucaryotic proteins comprising disulphide bridges after expression in procaryotes |
| 05/03/1994 | CA1329156C Immunoglobulin conjugates |
| 05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
| 04/30/1994 | CA2109481A1 Anti-metastatic vaccine |
| 04/28/1994 | WO1994009368A1 Particles having gelatin-aminodextran coatings of and processes for making same |
| 04/28/1994 | WO1994009364A1 Method of inhibiting binding of amyloid precursor protein to beta-amyloid protein |
| 04/28/1994 | WO1994009160A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | WO1994009155A1 Methods of detecting alzheimer's disease |
| 04/28/1994 | WO1994009148A1 Process for producing major histocompatibility antigen class ii protein and material having the same immobilized thereon |
| 04/28/1994 | WO1994009141A1 Genes that encode a surface protein of p. carinii |
| 04/28/1994 | WO1994009140A1 Plasmodium falciparum antigens inducing protective antibodies |
| 04/28/1994 | WO1994009139A1 S-locus receptor kinase gene in a self-incompatible brassica napus line |
| 04/28/1994 | WO1994009138A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | WO1994009135A1 Cyclin complex rearrangement and uses related thereto |
| 04/28/1994 | WO1994009134A2 Modified ciliary neurotrophic factors |
| 04/28/1994 | WO1994009133A1 Protein partner screening assays and uses thereof |
| 04/28/1994 | WO1994009132A1 Human cd26 and methods for use |
| 04/28/1994 | WO1994009130A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
| 04/28/1994 | WO1994009128A1 Therapeutic treatment for inhibiting vascular restenosis |
| 04/28/1994 | WO1994009124A1 Dna compounds comprising sequences encoding mannuronan c-5-epimerase |
| 04/28/1994 | WO1994009120A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | WO1994009119A1 Remyelination using neural stem cells |
| 04/28/1994 | WO1994009117A1 Direct selection of cells by secretion product |
| 04/28/1994 | WO1994009116A1 Cho cells expressing human endothelin receptors |
| 04/28/1994 | WO1994009039A1 New protein that lengthens blood coagulation time, derived from the land leech haemadipsa sylvestris |
| 04/28/1994 | WO1994009037A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
| 04/28/1994 | WO1994009036A1 Thrombus detection using radiolabelled disintegrins |
| 04/28/1994 | WO1994009035A1 New influenza virus peptides, diagnostics and vaccines |
| 04/28/1994 | WO1994009034A1 Clot directed anticoagulant, process for making same and methods of use |
| 04/28/1994 | WO1994009032A1 Methods and compositions for detecting anti-hepatitis e virus activity |
| 04/28/1994 | WO1994009028A1 Process for purifying recombinant growth factor |
| 04/28/1994 | WO1994009027A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | WO1994009023A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
| 04/28/1994 | WO1994008941A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | WO1994008623A1 Injectable lecithin gel |
| 04/28/1994 | WO1994008620A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 04/28/1994 | WO1994008618A1 Oral tolerance and immune suppression in the treatment of aids |
| 04/28/1994 | WO1994008611A1 GROWTH HORMONE FRAGMENT hGH 108-129 |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008601A1 Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates |
| 04/28/1994 | WO1994008600A1 Inhibition of signal transduction molecules |
| 04/28/1994 | WO1994008597A1 Methods for the detection of antigen-specific immune complexes |
| 04/28/1994 | WO1994008454A1 Methods, compositions and screening assays relating to autoimmune disease |
| 04/28/1994 | WO1994008449A1 Crucifer acc synthase and uses thereof |
| 04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
| 04/28/1994 | DE4235718A1 New HIV-type immune deficiency virus ECACC V 92092318 |
| 04/28/1994 | DE4228457A1 Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells |
| 04/28/1994 | CA2147622A1 Methods and compositions for detecting anti-hepatitis e virus activity |
| 04/28/1994 | CA2147466A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | CA2147273A1 Thrombus detection using radiolabelled disintegrins |
| 04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
| 04/28/1994 | CA2147167A1 A new class of rptpases: their structural domains and ligands |
| 04/28/1994 | CA2147127A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | CA2146929A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | CA2146869A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | CA2146862A1 The taga gene and methods for detecting predisposition to peptic ulceration |
| 04/28/1994 | CA2146766A1 Polypeptides with a serotoninergic receptor activity (5ht2c) and uses therefor |
| 04/28/1994 | CA2146446A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | CA2146161A1 Crucifer acc synthase and uses thereof |
| 04/28/1994 | CA2144738A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 04/28/1994 | CA2125871A1 Process for preparing major histocompatibility antigen class ii protein and materials in which the same is bound |
| 04/28/1994 | CA2125784A1 Injectable lecithin gel |
| 04/27/1994 | EP0594492A2 Growth inhibitory factor |
| 04/27/1994 | EP0594311A1 Metastasis-inhibiting protein, and DNA encoding said protein |
| 04/27/1994 | EP0594235A2 Method of purification of amylase, purified amylase so obtained and uses of purified amylase |
| 04/27/1994 | EP0593868A1 PEG-interferon conjugates |
| 04/27/1994 | EP0593857A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 04/27/1994 | EP0593794A1 Isolated mink growth hormone genes, novel recombinant DNA and methods for producing mink growth hormone |
| 04/27/1994 | EP0593757A1 Method for obtaining polypeptides in a cell-free system |
| 04/27/1994 | EP0593755A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 04/27/1994 | EP0593754A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 04/27/1994 | EP0593663A1 Method and assay system for neurotrophin activity |
| 04/27/1994 | EP0593620A1 Herpes virus proteinase and method of assaying |
| 04/27/1994 | EP0593618A1 Screening assay for the detection of dna-binding molecules |
| 04/27/1994 | EP0593585A1 Peptide which abrogates tnf and/or lps toxicity |
| 04/27/1994 | EP0593580A1 Sequences characteristic of human gene transcription product |
| 04/27/1994 | EP0593572A1 PEN POLYMORPHISM OF HUMAN PLATELET MEMBRANE GLYCOPROTEIN IIIa AND DIAGNOSTIC AND THERAPEUTIC APPLICATION THEREOF |
| 04/27/1994 | EP0593516A1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 04/27/1994 | EP0593501A1 Biocidal proteins |
| 04/27/1994 | EP0485471B1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
| 04/27/1994 | CN1085943A Liquid detergents containing a peptide aldehyde |
| 04/27/1994 | CN1085913A Glucagon-like peptide and insulinotropin derivatives |
| 04/27/1994 | CN1085804A Stabilized somatotropin for parenterai administration |
| 04/26/1994 | US5306863 Transformed plant which expresses an insecticidally effective amount of a Bowman-Birk tryspin inhibitor from Vigna unguiculata in leaves, stems or roots, and a method for the production thereof |
| 04/26/1994 | US5306812 Has capability of binding to heavy chain variable regions of antibodies in an antigen independent manner and can separate antigen/antibody complexes |
| 04/26/1994 | US5306811 Isolation by concentration or separation |
| 04/26/1994 | US5306809 Acid-labile linker molecules |